These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 7906197

  • 1. CD4+ T-cells from mice immunized to syngeneic sarcomas recognize distinct, non-shared tumor antigens.
    Cohen PA, Cohen PJ, Rosenberg SA, Mulé JJ.
    Cancer Res; 1994 Feb 15; 54(4):1055-8. PubMed ID: 7906197
    [Abstract] [Full Text] [Related]

  • 2. Differential recognition of murine tumor-associated oncofetal transplantation antigen and individually specific tumor transplantation antigens by syngeneic cloned BALB/c and RFM mouse T cells.
    Rohrer JW, Rohrer SD, Barsoum A, Coggin JH.
    J Immunol; 1994 Jan 15; 152(2):754-64. PubMed ID: 7904290
    [Abstract] [Full Text] [Related]

  • 3. Autoreactive and heat shock protein 60-recognizing CD4+ T-cells show antitumor activity against syngeneic fibrosarcoma.
    Harada M, Matsuzaki G, Yoshikai Y, Kobayashi N, Kurosawa S, Takimoto H, Nomoto K.
    Cancer Res; 1993 Jan 01; 53(1):106-11. PubMed ID: 8093229
    [Abstract] [Full Text] [Related]

  • 4. Murine epidermal Langerhans cells and splenic dendritic cells present tumor-associated antigens to primed T cells.
    Cohen PJ, Cohen PA, Rosenberg SA, Katz SI, Mulé JJ.
    Eur J Immunol; 1994 Feb 01; 24(2):315-9. PubMed ID: 7905414
    [Abstract] [Full Text] [Related]

  • 5. Anatomic location defines antigen presentation by dendritic cells to T cells in response to intravenous soluble antigens.
    Chung Y, Chang JH, Kim BS, Lee JM, Kim HY, Kang CY.
    Eur J Immunol; 2007 Jun 01; 37(6):1453-62. PubMed ID: 17474148
    [Abstract] [Full Text] [Related]

  • 6. Methylcholanthrene-induced mouse sarcomas express individually distinct major histocompatibility complex class I-associated peptides recognized by specific CD8+ T-cell lines.
    Kono K, Petersson M, Ciupitu AM, Wen T, Klein G, Kiessling R.
    Cancer Res; 1995 Dec 01; 55(23):5648-55. PubMed ID: 7585649
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T-cell receptor transgenic analysis of tumor-specific CD8 and CD4 responses in the eradication of solid tumors.
    Marzo AL, Lake RA, Robinson BW, Scott B.
    Cancer Res; 1999 Mar 01; 59(5):1071-9. PubMed ID: 10070965
    [Abstract] [Full Text] [Related]

  • 9. Expressed Salmonella antigens within macrophages enhance the proliferation of CD4+ and CD8+ T lymphocytes by means of bystander dendritic cells.
    Eguchi M, Sekiya Y, Kikuchi Y, Takaya A, Yamamoto T, Matsui H.
    FEMS Immunol Med Microbiol; 2007 Aug 01; 50(3):411-20. PubMed ID: 17573927
    [Abstract] [Full Text] [Related]

  • 10. Simian virus 40 large-T-antigen-specific rejection of mKSA tumor cells in BALB/c mice is critically dependent on both strictly tumor-associated, tumor-specific CD8(+) cytotoxic T lymphocytes and CD4(+) T helper cells.
    Utermöhlen O, Schulze-Garg C, Warnecke G, Gugel R, Löhler J, Deppert W.
    J Virol; 2001 Nov 01; 75(22):10593-602. PubMed ID: 11602701
    [Abstract] [Full Text] [Related]

  • 11. Cross-reacting tumor associated transplantation antigen on primary 3-methylcholanthrene-induced BALB/c sarcomas.
    Coggin JH.
    Mol Biother; 1989 Nov 01; 1(4):223-8. PubMed ID: 2818874
    [Abstract] [Full Text] [Related]

  • 12. Rejection of an IA+ variant line of FBL-3 leukemia by cytotoxic T lymphocytes with CD4+ and CD4-CD8- T cell receptor-alpha beta phenotypes generated in CD8-depleted C57BL/6 mice.
    Yoshimura A, Shiku H, Nakayama E.
    J Immunol; 1993 Jun 01; 150(11):4900-10. PubMed ID: 8496592
    [Abstract] [Full Text] [Related]

  • 13. Augmentation of antitumor immune responses after adoptive transfer of bone marrow derived from donors immunized with tumor lysate-pulsed dendritic cells.
    Asavaroengchai W, Kotera Y, Koike N, Pilon-Thomas S, Mulé JJ.
    Biol Blood Marrow Transplant; 2004 Aug 01; 10(8):524-33. PubMed ID: 15282530
    [Abstract] [Full Text] [Related]

  • 14. IL-12 is both required and sufficient for initiating T cell reactivity to a class I-restricted tumor peptide (P815AB) following transfer of P815AB-pulsed dendritic cells.
    Bianchi R, Grohmann U, Belladonna ML, Silla S, Fallarino F, Ayroldi E, Fioretti MC, Puccetti P.
    J Immunol; 1996 Aug 15; 157(4):1589-97. PubMed ID: 8759743
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. CIITA-induced MHC class II expression in mammary adenocarcinoma leads to a Th1 polarization of the tumor microenvironment, tumor rejection, and specific antitumor memory.
    Mortara L, Castellani P, Meazza R, Tosi G, De Lerma Barbaro A, Procopio FA, Comes A, Zardi L, Ferrini S, Accolla RS.
    Clin Cancer Res; 2006 Jun 01; 12(11 Pt 1):3435-43. PubMed ID: 16740768
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.